InvestorsHub Logo
Followers 829
Posts 119620
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 12413

Thursday, 08/28/2014 11:28:51 AM

Thursday, August 28, 2014 11:28:51 AM

Post# of 20689
MYL’s 40mg Copaxone ANDA has also been accepted by the FDA for review, according to a PR that just hit the wires:

http://finance.yahoo.com/news/mylans-anda-three-times-per-152000383.html

MYL claims it is eligible for shared first-to-file 180-day H-W exclusivity (implicitly acknowledging MNTA's PR).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”